Core Insights - The latest net value of Ping An Medical Health Mixed C (020137) is 1.9567 yuan, reflecting a decline of 4.93% [1] - The fund's performance over the past month shows a return of -2.07%, ranking 3393 out of 3457 in its category; over the last three months, it has achieved a return of 25.32%, ranking 25 out of 3416; and since the beginning of the year, it has returned 26.39%, ranking 59 out of 3387 [1] Fund Holdings - The top ten stock holdings of Ping An Medical Health Mixed C account for a total of 83.49%, with the largest positions being: - Kangfang Biotech (9.32%) - BeiGene-U (9.13%) - Boli Tianheng (8.95%) - Zai Lab (8.87%) - Yunding Xinyao-B (8.79%) - Nuocheng Jianhua-U (8.47%) - Zexing Pharmaceutical-U (8.47%) - Ailisi (8.27%) - Kelun-Botai (7.31%) - Dize Pharmaceutical-U (5.91%) [1] Fund Manager Profile - Zhou Sicong, the fund manager of Ping An Medical Health Mixed C, has a master's degree and has held various positions in the investment management industry, including roles at Yin Hua Fund Management and Changsheng Fund Management. She joined Ping An Fund Management in May 2023 [2]
5月12日平安医疗健康混合C净值下跌4.93%,近1个月累计下跌2.07%
Sou Hu Cai Jing·2025-05-12 12:40